PMI picardmedical.com: Forward P/S Multiple

Picard Medical Inc (PMI) implements life support systems that are currently aggressively capturing market share. High FDA barriers and the complexity of equipment operation protect the business from competitors, as reflected in the company's forward P/S trend on the GURU.Markets chart, where 2.40 shows the current value of the metric. The enterprise's success is based on government funding and the recognition of new cardiological developments by physicians.

picardmedical.com - PMI Market Cap to Expected Sales Ratio (period 08/30/2025 - 11/15/2026)

Metric breakdowns and analytics for picardmedical.com (PMI)

- current price and projected stock value:

Stock Price picardmedical.com|PMI - Average Forecast Price

- company stock capitalization data:

Market Capitalization Picard Medical Inc.|PMI - Business Value

- issuer book value statistics:

Book Value per Share Picard Medical|PMI - Book Valuation of Business|Market Capitalization to Book Value Ratio picardmedical.com|PMI - Cumulative Company Assets

- company total debt and liquidity indicators:

- financial results and valuation multiples details:

PMI - Annual Net Income|Future Profit Picard Medical Inc|PMI - P/E Multiple|Forward P/E Multiple picardmedical.com|PMI - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Picard Medical|PMI - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Picard Medical|PMI - Net earnings per share for the last 12 months|Quarterly EPS earnings growth picardmedical.com|PMI - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Picard Medical Inc

- sales volume and revenue indicators:

PMI - Company Sales Volume|Company Future Sales Volume Picard Medical|PMI - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio Picard Medical|PMI - Trailing Twelve Months Sales Growth

Summary company analytics:Picard Medical Inc. (PMI)

Efficient logistics for heart support systems at Picard Medical Inc (PMI) directly impact revenue stability and margins. GURU.Markets tools visualize this correlation through the issuer's forward P/S, reflecting market value relative to expected sales. This metric recalculates the business valuation in real-time, identifying the gap between operational achievements and stock quotes. Analyzing this imbalance allows investors to avoid impulsive trades and recognize asset undervaluation in a timely manner.

Key competitors

Price-to-Projected Revenue Ratio Dexcom CGM DXCM|Penumbra Corp (PEN) - Market Cap to Future Revenue Ratio|Novanta Inc - Forward P/S Multiple|HAE (Haemonetics Corporation) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED Inc.) - Forward P/S Multiple|Pulse Corp (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Surmodics, Inc. SRDX|Forward P/S Multiple SENS (senseonics.com)|Forward P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|Outset Medical Corp (OM) - Price-to-Projected Revenue Ratio|SmartVest - Forward Price to Sales|LNSR (LENSAR Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio AVITA Medical Inc. RCEL|Price-to-Projected Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Projected Price to Revenue|EDAP TMS SA - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx LUNG|TELA Bio (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corp.)|Price-to-Projected Revenue Ratio sensushealthcare.com|Forward Price-to-Revenue Multiple Zynex, Inc. (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio inspira-technologies.com IINN|Price to Expected Revenue Ratio ICU (SeaStar Medical Holding Corp.)|IRIX: Forward Price-to-Revenue Multiple|ibs.inc - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|Future Price to Revenue PFSA (Profusa Inc.)|Forward Price-to-Revenue Multiple SSKN|Price-to-Projected Revenue Ratio GCTK|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Projected Revenue|Forward P/S Multiple NUWE (Nuwellis Corp)|Forward Price to Sales AEMD|ASXC - Price-to-Projected Revenue Ratio|Projected Price to Revenue Avinger, Inc (AVGR)|BSGM: Forward P/S Multiple|Cutera (CUTR) - Forward P/S Multiple|KNW (Know Labs) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Inari Medical (NARI)|Price-to-Projected Revenue Ratio nevro.com (NVRO)|RSLS (ReShape Lifesciences, Inc.) - Forward Price to Sales|Forward P/S Multiple SILK (Silk Road Medical)